FC Cincinnati and Hoxworth Blood Center run a blood drive in August, offering an exclusive team jersey to donors while promoting community involvement.

The University of Cincinnati Cancer Center's Blood Cancer Healing Center celebrates its first anniversary, focusing on holistic care that combines medical treatment with emotional and spiritual support.

The article discusses a study from the University of Cincinnati linking socioeconomic status and worsened Parkinson's disease symptoms, highlighting healthcare disparities.

The article discusses 'Japanese walking', combining interval and mindful walking, endorsed by science and becoming popular on TikTok, which may benefit physical and mental health.

Researchers at the University of Cincinnati have reviewed why EGFR-targeted therapies face resistance in certain cancers, looking into new combination therapies that could improve treatment outcomes.

A study in Clinical Gastroenterology and Hepatology suggests that inflammation, not symptoms, disrupts sleep in IBD patients, based on data from wearable tech.

Mosquitoes in Hamilton County tested positive for West Nile virus, with no human cases reported. Health officials began larvicide treatments and advise public on preventive measures.

Neurosurgery expert Joseph Cheng suggests that rest might worsen certain back conditions like axial spondyloarthritis, while it's beneficial for ankylosing spondylitis. Back pain management should be tailored to the individual's condition.

A study in "Neurogastroenterology & Motility" suggests the low-FODMAP diet may reduce IBS symptoms better than the Mediterranean diet, offering a potential dietary approach for those affected by IBS.

Study links early onset of type 1 diabetes in children to higher risks of heart conditions, early death, and reduced lifespan, with each additional year before diagnosis potentially lowering cardiovascular mortality risk.

Study by D2Type Health suggests switching diet soda for water may aid in weight loss and diabetes remission, but Dr. Cohen expresses skepticism about the findings.

The trial of a new drug, bexobrutideg, shows promising results for chronic lymphocytic leukemia patients previously treated extensively, with an 80.9% response rate observed.

University of Cincinnati biologists are studying the lifecycle of the Chagas disease parasite to develop a cure, aiming to prevent transmission from insects to humans.